Current Neuro-Oncology
Volume
28 Number 13
10 May 2026
Home > Publications > Current Neuro-Oncology > Volume 28, Year 2026 > Number 13, 10 May
Bosio A, Maccari M, Padovan M, Caccese M, Bolshinsky M, Galiano A,
Cavallin F, Bellu L, Pasqualetti F, Parisi A, Librizzi G,
Pintacuda G, Salvalaggio A, Zoccarato M, Ius T, Volpin F, Denaro
L, Lonardi S, Lombardi G.
Real-world
management and long-term outcomes in adolescent, young adult, and
adult medulloblastoma: Experience from a monocentric series with
multimodal and targeted approaches.
Neurooncol
Pract. 2025 Oct 24;13(2):385-393. doi:
10.1093/nop/npaf110. PMID:
42111030. ˍ
ˍ
Jenkinson MD, Bulbeck H, Burns J, Rooney AG, Dobbie R, Carruthers
J, Lessels S, Watson R, Gribben C, Robinson T, Vale L, Thompson G,
Erridge SC, Watts C, Marson AG, Grant R; SPRING study
Collaborators.
Seizure
prophylaxis in glioma surgery (SPRING): A multi-center, unblinded,
randomized trial.
Neurooncol
Pract. 2025 Nov 5;13(2):252-261. doi:
10.1093/nop/npaf114. PMID:
42111024. Trial
registration ID: ISRCTN 49474281, EudraCT
2018-001312-30. ˍ
Kim H, Gomez A, Dixit KS.
First
report of a clinical and radiologic response to vorasidenib in a
patient with isocitrate dehydrogenase-mutant brainstem
astrocytoma.
Neurooncol
Pract. 2025 Dec 31;13(2):428-431. doi:
10.1093/nop/npaf131. PMID:
42111031˰ ˍ
Rodriguez A, Dixit K, O'Hara RM Jr, Vojnic M.
Efficacy
of tepotinib in patients with high-grade glioma with MET
alterations:
A case series.
Neurooncol
Pract. 2025 Dec 31;13(2):422-427. doi:
10.1093/nop/npaf130. PMID:
42111027. ˍ
Attinà G, Maurizi P, Romano A, Talloa D, Verdolotti T,
Frassanito P, Tamburrini G, Chiesa S, Mastrangelo S, Ruggiero
A.
Concurrent chemoradiotherapy with
temozolomide in newly pediatric diffuse intrinsic pontine glioma:
clinical outcomes and safety analysis.
Transl
Pediatr. 2026 Mar 26;15(4):140. doi:
10.21037/tp-2025-1-942. PMID:
42158701. ˍ
Qureshi M, Peereboom D, Zabor E, Angelov L, Barnett G, Dhawan A,
Grabowski M, Hufsey R, Lobbous M, Malkin M, Lucas A, Mohammadi A,
Soni P, Stevens G, Torres-Trejo A, Lathia J.
TIP26-314:
Targeting Macrophage Migration Inhibitory Factor: A Phase 2 and
Pharmacodynamic Study of Sitagliptin in Patients With Progressive
Grade 4 Gliomas.
J
Natl Compr Canc Netw. 2026 Mar 31;24(3.5):TIP26-314.
doi:
10.6004/jnccn.2025.7219. PMID:
42066799. Trial registration ID: Unidentified˰
ˍ
Rüssli S, Descombes C, Terrapon APR, Hinsberger M, Maragkou
T, Zubak I, Häni L, Schucht P, Raabe A, Goldberg J.
Higher
perioperative dexamethasone exposure is associated with shorter
survival in glioblastoma.
Neurooncol
Adv. 2026 Apr 13;8(1):vdag099. doi:
10.1093/noajnl/vdag099. PMID:
42100168. ˍ
Zhang Y, Wang Z, Wang Y, Li E, Wu F, Hou L, Yin B, Qiang B, Han W,
Peng X.
Clofoctol
as a novel senolytic drug eliminating therapy-induced senescent
glioma cells.
Neurooncol
Adv. 2026 Apr 13;8(1):vdag102. doi:
10.1093/noajnl/vdag102. PMID:
42109835. ˍ
Wang X, Niu T, Xia J, Liu J, Sun M.
Promising
efficacy of teniposide in H3K27M mutant diffuse midline gliomas: a
case report.
Front
Oncol. 2026 Apr 16;16:1784250. doi:
10.3389/fonc.2026.1784250. PMID:
42078816. ˍ
Duan Y, Yuan L, Niu Q, Li Y, Chen X, Zhang X, Zou D, Zhou Z.
Effects of Sandplay Therapy on
Emotional Problems and Quality of Life in Children With Central
Nervous System Tumors: A Randomized Controlled Trial.
Oncol
Nurs Forum. 2026 Apr 29;53(3):1-16. doi:
10.1188/26.ONF.e26535299. PMID:
42189650. ˍ